The key difference is not potency but duration: continuous versus pulsatile GH stimulation, each with distinct physiological implications
As reported by the Australian Journal of Pharmacy , Novo Nordisk, the company that developed and supplies the drug, updated its website earlier this month to confirm the continued supply challenges
designed and synthesized a new series of DPP-4 inhibitors containing an imidazo[1,2-a]pyridine scaffold
Back Dupr, J (26 Sept 1964) 'An intestinal hormone affecting glucose disposal in man', The Lancet , 672-73
We did not identify any significant difference in the distribution of NSAID usage
some are investigational drugs not approved by the FDA